Crossmark

Correction: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia

Crossref DOI link: https://doi.org/10.1186/s12934-024-02622-8

Published Online: 2024-12-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shawky, Heba https://orcid.org/0000-0001-8403-1143
Tabll, Ashraf A. https://orcid.org/0000-0001-7041-5445
Elshenawy, Reem M. https://orcid.org/0000-0001-7861-238X
Helmy, Naiera M. https://orcid.org/0000-0003-3788-3372
Moustafa, Rehab I. https://orcid.org/0000-0002-8277-8304
Elesnawy, Yasser K. https://orcid.org/0000-0002-9863-5551
Abdelghany, Marwa M. https://orcid.org/0000-0001-7046-9494
El-Abd, Yasmine S. https://orcid.org/0000-0002-8212-6146
License Information

Text and Data Mining valid from 2024-12-23

Version of Record valid from 2024-12-23
More Information

Article History

First Online: 23 December 2024